Healthcare -
Biotechnology - NASDAQ - US
$ 9.24
-2.74 %
$ 460 M
Market Cap
-2.79
P/E
MLYS - STOCK-BASED COMPENSATION
Stock-based Compensation MLYS - Mineralys Therapeutics, Inc.
5.06 M
LAST VALUE
695.30%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR